Log in
TSE:BHC

Bausch Health Companies Stock Forecast, Price & News

C$22.85
+0.64 (+2.88 %)
(As of 09/17/2020 12:00 AM ET)
Add
Compare
Today's Range
C$21.92
Now: C$22.85
C$23.31
50-Day Range
C$20.31
MA: C$22.65
C$26.83
52-Week Range
C$16.30
Now: C$22.85
C$42.15
Volume916,209 shs
Average Volume750,965 shs
Market CapitalizationC$8.11 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. was founded in 1983 and is headquartered in Laval, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.79 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone514-744-6792

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$8.11 billion
Cash FlowC$2.84 per share
Book ValueC$1.34 per share

Profitability

Miscellaneous

Employees21,100
Market CapC$8.11 billion
Next Earnings Date11/2/2020 (Estimated)
OptionableOptionable
C$22.85
+0.64 (+2.88 %)
(As of 09/17/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BHC News and Ratings via Email

Sign-up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Bausch Health Companies (TSE:BHC) Frequently Asked Questions

How has Bausch Health Companies' stock price been impacted by Coronavirus (COVID-19)?

Bausch Health Companies' stock was trading at C$25.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BHC stock has decreased by 9.8% and is now trading at C$22.85.
View which stocks have been most impacted by COVID-19
.

When is Bausch Health Companies' next earnings date?

Bausch Health Companies is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Bausch Health Companies
.

How were Bausch Health Companies' earnings last quarter?

Bausch Health Companies Inc (TSE:BHC) issued its earnings results on Thursday, August, 6th. The company reported $0.65 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.90 by $0.25. The company had revenue of $2.31 billion for the quarter, compared to the consensus estimate of $2.45 billion.
View Bausch Health Companies' earnings history
.

Who are some of Bausch Health Companies' key competitors?

What other stocks do shareholders of Bausch Health Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Enbridge (ENB), Aurora Cannabis (ACB), Manulife Financial (MFC), Bank of Nova Scotia (BNS), Toronto-Dominion Bank (TD), BlackBerry (BB), Suncor Energy (SU), Nutrien (NTR) and ARC Resources (ARX).

Who are Bausch Health Companies' key executives?

Bausch Health Companies' management team includes the following people:
  • Mr. Joseph C. Papa, CEO & Chairman (Age 64)
  • Mr. Paul S. Herendeen, Exec. VP & CFO (Age 63)
  • Ms. Christina M. Ackermann, Exec. VP & Gen. Counsel (Age 54)
  • Mr. Thomas J. Appio, Pres & Co-Head Bausch + Lomb/International (Age 57)
  • Mr. Joseph Gordon, Pres & Co-Head Bausch + Lomb/International (Age 55)

What is Bausch Health Companies' stock symbol?

Bausch Health Companies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BHC."

How do I buy shares of Bausch Health Companies?

Shares of BHC and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Bausch Health Companies' stock price today?

One share of BHC stock can currently be purchased for approximately C$22.85.

How big of a company is Bausch Health Companies?

Bausch Health Companies has a market capitalization of C$8.11 billion and generates C$8.11 billion in revenue each year. Bausch Health Companies employs 21,100 workers across the globe.

What is Bausch Health Companies' official website?

The official website for Bausch Health Companies is www.valeant.com.

How can I contact Bausch Health Companies?

The company can be reached via phone at 514-744-6792.

This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.